Compass Therapeutics (CMPX) Earnings Date & Reports

Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

CMPX is expected to report earnings to fall 4.62% to -12 cents per share on November 11

Compass Therapeutics CMPX Stock Earnings Reports

Q3'26

Est.

$-0.12

Q2'26

Missed

by $0.02

Q1'26

Est.

$-0.10

Q4'25

Beat

by $0.01

Q3'25

Beat

by $0.06

The last earnings report on August 06 showed earnings per share of -12 cents, missing the estimate of -10 cents. With 741.31K shares outstanding, the current market capitalization sits at 405.20M.

View a ticker or compare two or three

CMPX

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days